PL445404A1 - Nowa pochodna 1,3,5-triazyny i jej zastosowanie - Google Patents

Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Info

Publication number
PL445404A1
PL445404A1 PL445404A PL44540423A PL445404A1 PL 445404 A1 PL445404 A1 PL 445404A1 PL 445404 A PL445404 A PL 445404A PL 44540423 A PL44540423 A PL 44540423A PL 445404 A1 PL445404 A1 PL 445404A1
Authority
PL
Poland
Prior art keywords
triazine
application
new derivative
new
derivative
Prior art date
Application number
PL445404A
Other languages
English (en)
Other versions
PL247377B1 (pl
Inventor
Damian Kułaga
Anna Karolina Drabczyk
Izabela SIEMIŃSKA
Original Assignee
Politechnika Krakowska im. Tadeusza Kościuszki
Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Krakowska im. Tadeusza Kościuszki, Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie filed Critical Politechnika Krakowska im. Tadeusza Kościuszki
Priority to PL445404A priority Critical patent/PL247377B1/pl
Publication of PL445404A1 publication Critical patent/PL445404A1/pl
Publication of PL247377B1 publication Critical patent/PL247377B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest nowa pochodna tryptamino-1,3,5-triazyny, którą stanowi chlorowodorek N2-(2-(1H-indol-3-ilo)etylo)-6-(4-(4'-fluoro-[1,1'-bifen]-2-ylo)piperaz-1-ylo)-1,3,5-triazyno-2,4-diaminy o wzorze 1 do zastosowania w leczeniu nowotworu jelita grubego.
PL445404A 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie PL247377B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL445404A PL247377B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL445404A PL247377B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Publications (2)

Publication Number Publication Date
PL445404A1 true PL445404A1 (pl) 2024-12-30
PL247377B1 PL247377B1 (pl) 2025-06-23

Family

ID=96093029

Family Applications (1)

Application Number Title Priority Date Filing Date
PL445404A PL247377B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Country Status (1)

Country Link
PL (1) PL247377B1 (pl)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2268635T1 (sl) * 2008-04-21 2015-10-30 Taigen Biotechnology Co., Ltd. Heterociklične spojine
US9775835B2 (en) * 2012-08-06 2017-10-03 Sirga Advanced Biopharma, Inc. Small molecule inhibitors of viral protein interactions with human t-RNA

Also Published As

Publication number Publication date
PL247377B1 (pl) 2025-06-23

Similar Documents

Publication Publication Date Title
NZ580671A (en) Pyrimidine derivatives
ES2395392T3 (es) Derivados aminoácidos multicíclicos y métodos de su uso
PE20211411A1 (es) Compuestos de anillo fusionado
PE20090895A1 (es) Derivados de triazol como inhibidores de la jak quinasa
PE20211375A1 (es) Compuestos de 4-aminoisoindolina-1,3-diona sustituidos y su uso para el tratamiento de linfoma
CY1110343T1 (el) 2-(πυριδιν-2-υλο)-πυριμιδινες και η χρησιμοποιηση του για την καταπολεμηση επιζημιων μυκητων
CY1117015T1 (el) 2,4-δι(φαινυλαμινο)-πυριμιδινες χρησιμες στην αντιμετωπιση νεοπλασματικων νοσων, φλεγμονωδων διαταραχων και διαταραχων του ανοσοποιητικου συστηματος
RU2014124953A (ru) Производные аминопиридина в качестве модуляторов богатой лейцином повторной киназы 2 (lrrk2)
PE20161416A1 (es) Derivados de benzamida para la inhibicion de la actividad abl1, abl2 y bcr-abl1
PA8595201A1 (es) Preparacion de quinazolinas substituidas
CU20090196A7 (es) Metabolitos de derivados del (tio)-carbamoil-ciclohexano
NO20061506L (no) Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav
AR031152A1 (es) Tratamientos nuevos para el sindrome de piernas inquietas
PE20210096A1 (es) Inhibidor de ret para uso en tratar cancer que tiene una alteracion de ret
PL378064A1 (pl) Pirymidyny i triazyny hamujące replikację wirusa HIV
CL2008002398A1 (es) Compuestos derivados de 6-(fenil piperidina) pirimidinas fusionadas con imidazol, triazol o pirozol, inhibidores de la via pi3k/akt; composicion farmaceutica; combinacion farmaceutica; y uso de los compuestos para el tratamiento de la neoplasia benigna y/o maligna y para el cancer.
MX2023001803A (es) Derivados de 2,4-diaminoquinazolina y usos medicos de los mismos.
ATE355265T1 (de) Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren
ZA202006071B (en) Antiproliferation compounds and uses thereof
ATE396970T1 (de) 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri
EA201070366A1 (ru) 3-метил-2-((2s)-2-(4-(3-метил-1,2,4-оксадиазол-5-ил)фенил)морфолино)-6-(пиримидин-4-ил)пиримидин-4(3н)-он в качестве ингибитора тау-протеинкиназы
GT200600105A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos.
PE20210417A1 (es) Nuevo derivado de amina heterociclico y composicion farmaceutica que lo comprende
CY1109129T1 (el) Χρηση παραγωγων πυρρολιου για καταπολεμηση του αγχους
PH12021550374A1 (en) Small molecule menin inhibitors